Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis
Journal of Oral Pathology & Medicine · 2023-05 · 52 (5) · 402-409
DOI: 10.1111/jop.13359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, online erschienen am 03.10.2022. Verfasst von Gabriela Vivili Domingues Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, Brazil. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).
Abstract (Originalsprache)
Background
While the relevance of the World Health Organization histopathological grading system as a prognostic tool for oral squamous cell carcinoma has received many critics, other histopathological features such as tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding are displaying promising results. Here, we evaluated the prognostic impact of the incorporation of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding into World Health Organization histopathological grading for patients with oral squamous cell carcinoma.
Methods
A total of 95 patients with early‐stage oral squamous cell carcinoma were enrolled in the study, and World Health Organization tumor grading, tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding were evaluated in surgical slides stained with hematoxylin and eosin. Survival analyses for cancer‐specific survival and disease‐free survival were performed using Cox regression models, and receiver operating characteristic curves were applied for assessment of the performance of the combinations.
Results
Tumor‐stroma ratio (stroma‐rich) was significantly and independently associated with both shortened cancer‐specific survival and poor disease‐free survival, individually and in combination with World Health Organization histopathological grading. The combination of tumor‐stroma ratio with World Health Organization grading did not improve the discriminatory ability compared to tumor‐stroma ratio alone. Although low tumor‐infiltrating lymphocytes were associated with shortened cancer‐specific survival, the association did not withstand multivariate analysis. However, in combination with World Health Organization grading, low tumor‐infiltrating lymphocytes were independently associated with poor cancer‐specific survival. The combination of tumor‐infiltrating lymphocytes and World Health Organization histopathological grading displayed a better discrimination of poor cancer‐specific survival than tumor‐infiltrating lymphocytes alone, but not at a significant level.
Conclusion
Our findings support tumor‐stroma ratio as a potential prognostic marker for patients with oral squamous cell carcinoma, and the incorporation of tumor‐infiltrating lymphocytes into the World Health Organization grading system improves the prognostic ability of the tumor grading alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Diagnosis, School of Dentistry, University of Campinas, Piracicaba, Brazil.
- Graduate Program in Oral Biology, School of Dentistry, University of Campinas, Piracicaba, Brazil.
- School of Dentistry, University of Western Paulista (UNOESTE), Presidente Prudente, Brazil.
- Department of Pathology and Parasitology, Institute of Biomedical Sciences, Federal University of Alfenas, Alfenas, Brazil.
- Center of Biological Sciences and of the Health, School of Dentistry, State University of Western Parana, Cascavel, Brazil.
- Laboratory of Pathology and Molecular Biology, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
ORCID-Profile: Ricardo D Coletta
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Zitieren
APA
Silva, G. V. D., da Silva Dolens, E., Paranaíba, L. M. R., Ayroza, A. L. C., Gurgel Rocha, C. A., Almangush, A., Salo, T., Brennan, P. A., & Coletta, R. D. (2023). Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis. Journal of Oral Pathology & Medicine, 52(5), 402-409. https://doi.org/10.1111/jop.13359
Vancouver
Silva GVD, da Silva Dolens E, Paranaíba LMR, Ayroza ALC, Gurgel Rocha CA, Almangush A, et al. Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis. Journal of Oral Pathology & Medicine. 2023;52(5):402-409. doi:10.1111/jop.13359
BibTeX
@article{Silva2023,
author = {Silva, Gabriela Vivili Domingues and da Silva Dolens, Eder and Paranaíba, Lívia Máris Ribeiro and Ayroza, Ana Lúcia Carrinho and Gurgel Rocha, Clarissa Araujo and Almangush, Alhadi and Salo, Tuula and Brennan, Peter A and Coletta, Ricardo D},
title = {Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis},
journal = {Journal of Oral Pathology & Medicine},
year = {2023},
volume = {52},
number = {5},
pages = {402--409},
doi = {10.1111/jop.13359}
}
EUVIMED